Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
First international registry of early stage breast cancer patients launched
January 13th, 2005
Aventis, part of the sanofi-aventis Group, announced the launch of A Breast Cancer Registry of Adjuvant STrategies (ABREAST), the first international prospective registry of patients with early stage breast cancer. ABREAST will provide a current picture of "real-life" clinical practice as well as patient and disease characteristics. This registry, using standard patient selection criteria, data collection instruments, and definitions will collect data on the treatment and outcome of 36,000 women and men, aged 18 or older, and will provide an understanding of existing and evolving practice patterns. The ABREAST project will include randomly selected...
Source: Women's Health Weekly (2005-01-13)
|